Receipt of antibiotics in hospitalized patients and risk for clostridium difficile infection in subsequent patients who occupy the same bed

JAMA Internal Medicine

Volumn 176, Issue 12, 2016, Pages 1801-1808

  Freedberg, Daniel E ^a   Salmasian, Hojjat ^b   Cohen, Bevin ^c   Abrams, Julian A ^a   Larson, Elaine L ^c  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIMETABOLITE; CALCINEURIN INHIBITOR; CLOSTRIDIUM DIFFICILE TOXIN B; CREATININE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; MYCOPHENOLIC ACID; PREDNISONE; PROTON PUMP INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR; VANCOMYCIN; ANTACID AGENT; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EXPOSURE; FECES ANALYSIS; FEMALE; HEMODIALYSIS; HOSPITAL BED; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL WARD; WARD; BED; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HOSPITALIZATION; MICROBIOLOGY; NEW YORK; PEPTOCLOSTRIDIUM DIFFICILE; RISK; TRANSMISSION;

AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; BEDS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEW YORK CITY; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 85011277294     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.6193     Document Type: Article

References (41)

1. Lessa FC,Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-834.
2. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):1543-1549.
3. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med. 2007;167(10):1092-1097.
4. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med. 2015;175(4):626-633.
5. Miller AC, Polgreen LA, Cavanaugh JE, Polgreen PM. Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI. Am J Infect Control. 2016;44(7):825-829.
6. Brown KA, JonesM, Daneman N, et al. Importation, antibiotics, and Clostridium difficile infection in veteran long-term care: A multilevel case-control study. Ann Intern Med. 2016;164(12): 787-794.
7. Fekety R, Kim KH, Brown D, Batts DH, Cudmore M, Silva J Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med. 1981;70(4): 906-908.
8. Gerding DN, Muto CA, Owens RC Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis. 2008;46(suppl 1):S43-S49.
9. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204-210.
10. Lax S, Smith DP, Hampton-Marcell J, et al. Longitudinal analysis of microbial interaction between humans and the indoor environment. Science. 2014;345(6200):1048-1052.
11. Echaiz JF, Veras L, Zervos M, Dubberke E, Johnson L. Hospital roommates and development of health care-onset Clostridium difficile infection. Am J Infect Control. 2014;42(10):1109-1111.
12. Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201-206.
13. Dubberke ER, Carling P, Carrico R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(suppl 2):S48-S65.
14. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179(8):767-772.
15. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742-748.
16. Rashid MU, Zaura E, Buijs MJ, et al. Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencingmethods. Clin Infect Dis. 2015;60(suppl 2):S77-S84.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45 (6):613-619.
19. Brown KA, Fisman DN, Moineddin R, Daneman N. Themagnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: A hospital cohort study. PLoS One. 2014;9 (8):e105454.
20. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526. doi:10.1093/biomet/81.3.515
21. Polgreen PM, Yang M, Bohnett LC, Cavanaugh JE. A time-series analysis of clostridium difficile and its seasonal association with influenza. Infect Control Hosp Epidemiol. 2010;31(4):382-387.
22. Simmering JE, Polgreen LA, Campbell DR, Cavanaugh JE, Polgreen PM. Hospital transfer network structure as a risk factor for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015;36(9):1031-1037.
23. Vincent C, Manges AR. Antimicrobial use, human gut microbiota and Clostridium difficile colonization and infection. Antibiotics (Basel). 2015; 4(3):230-253.
24. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1(2): 101-114.
25. Hamel M, Zoutman D, O'Callaghan C. Exposure to hospital roommates as a risk factor for health care-associated infection. Am J Infect Control. 2010; 38(3):173-181.
26. Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis. 2000;31(3):717-722.
27. KingMF, Noakes CJ, Sleigh PA. Modeling environmental contamination in hospital singleand four-bed rooms. Indoor Air. 2015;25(6):694-707.
28. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006;166(18):1945-1951.
29. Bracco D, Dubois MJ, Bouali R, Eggimann P. Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med. 2007;33 (5):836-840.
30. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996; 23(4):767-772.
31. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007;28(2):123-130.
32. Carling PC, Parry MM, Rupp ME, Po JL, Dick B, Von Beheren S; Healthcare Environmental Hygiene Study Group. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 (11):1035-1041.
33. Goodman ER, Platt R, Bass R, Onderdonk AB, Yokoe DS, Huang SS. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol. 2008;29(7):593-599.
34. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):42-50.
35. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100(1):32-40.
36. Sasahara T, Ae R,Watanabe M, et al. Contamination of healthcare workers' hands with bacterial spores. J Infect Chemother. 2016;22(8): 521-525.
37. Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S, Donskey CJ. Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control. 2012;40(6):556-558.
38. Landelle C, Verachten M, Legrand P, Girou E, Barbut F, Brun-Buisson C. Contamination of healthcare workers' hands with Clostridium difficile spores after caring for patients with C difficile infection. Infect Control Hosp Epidemiol. 2014;35(1): 10-15.
39. Nerandzic MM, Cadnum JL, Pultz MJ, Donskey CJ. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis. 2010;10:197.
40. Longtin Y, Paquet-Bolduc B, Gilca R, et al. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C difficile infections: A quasi-experimental controlled study. JAMA Intern Med. 2016;176(6): 796-804.
41. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166(3):561-567.